ADRB2 and neoplasm: We show for the first time that systemic β-AR activation in vivo augments the mobilization, ex vivo expansion, and anti-tumor activity of TCR-γδ T-cells, and that some of these effects are largely mediated by β2-AR signaling and exercise-induced phenotypic shifts that promote a dominant activating signal via NKG2D.